Literature DB >> 9434681

Aricept-induced nightmares in Alzheimer's disease: 2 case reports.

J S Ross, J R Shua-Haim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9434681     DOI： 10.1111/j.1532-5415.1998.tb01033.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  13 in total

1.  Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.

Authors:  Jana R Cooke; Jose S Loredo; Lianqi Liu; Matthew Marler; Jody Corey-Bloom; Lavinia Fiorentino; Tamara Harrison; Sonia Ancoli-Israel
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Authors:  B P Imbimbo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake].

Authors:  M Singer; B Romero; E Koenig; H Förstl; H Brunner
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 4.  Non-pharmacologic management of sleep disturbance in Alzheimer's disease.

Authors:  R David; J Zeitzer; L Friedman; A Noda; R O'Hara; P Robert; J A Yesavage
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

Review 5.  The safety and tolerability of donepezil in patients with Alzheimer's disease.

Authors:  Stephen Jackson; Richard J Ham; David Wilkinson
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 6.  Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Authors:  David G Wilkinson; Paul T Francis; Elias Schwam; Jennifer Payne-Parrish
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Circadian rhythm disturbances in patients with Alzheimer's disease: a review.

Authors:  Dawit A Weldemichael; George T Grossberg
Journal:  Int J Alzheimers Dis       Date:  2010-09-02

8.  Sundown syndrome in persons with dementia: an update.

Authors:  Nina Khachiyants; David Trinkle; Sang Joon Son; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2011-11-04       Impact factor: 2.505

9.  A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.

Authors:  Basil H Ridha; Sebastian Crutch; Dawn Cutler; Christopher Frost; William Knight; Suzie Barker; Norah Epie; Elizabeth K Warrington; Riitta Kukkastenvehmas; Jane Douglas; Martin N Rossor
Journal:  Alzheimers Res Ther       Date:  2018-05-01       Impact factor: 6.982

10.  Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study.

Authors:  Stephen LaBerge; Kristen LaMarca; Benjamin Baird
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.